Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

965 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sepsis: current status, future prospects.
Marshall JC. Marshall JC. Curr Opin Crit Care. 2004 Aug;10(4):250-64. doi: 10.1097/01.ccx.0000134877.60312.f3. Curr Opin Crit Care. 2004. PMID: 15258497 Review. No abstract available.
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C; Monoclonal Anti-TNF: a Randomized Controlled Sepsis Study Investigators. Panacek EA, et al. Among authors: marshall jc. Crit Care Med. 2004 Nov;32(11):2173-82. doi: 10.1097/01.ccm.0000145229.59014.6c. Crit Care Med. 2004. PMID: 15640628 Clinical Trial.
Neutrophils in the pathogenesis of sepsis.
Marshall JC. Marshall JC. Crit Care Med. 2005 Dec;33(12 Suppl):S502-5. doi: 10.1097/01.ccm.0000186266.34541.5f. Crit Care Med. 2005. PMID: 16340434 Review. No abstract available.
965 results